Coca-Pelaz, AndrésAndrésCoca-PelazShah, Jatin PJatin PShahHernandez-Prera, Juan CJuan CHernandez-PreraGhossein, Ronald ARonald AGhosseinRodrigo, Juan PJuan PRodrigoHartl, Dana MDana MHartlOlsen, Kerry DKerry DOlsenShaha, Ashok RAshok RShahaZafereo, MarkMarkZafereoSuarez, CarlosCarlosSuarezNixon, Iain JIain JNixonRandolph, Gregory WGregory WRandolphMäkitie, Antti AAntti AMäkitieKowalski, Luiz PLuiz PKowalskiVander Poorten, VincentVincentVander PoortenSanabria, AlvaroAlvaroSanabriaGuntinas-Lichius, OrlandoOrlandoGuntinas-LichiusSimo, RicardRicardSimoZbären, PeterPeterZbärenAngelos, PeterPeterAngelosKhafif, AviAviKhafifRinaldo, AlessandraAlessandraRinaldoFerlito, AlfioAlfioFerlito2024-09-022024-09-022020-07https://boris-portal.unibe.ch/handle/20.500.12422/39154INTRODUCTION Aggressive variants of papillary thyroid cancer (PTC) have been described with increasing frequency. These variants include diffuse sclerosing variant, tall cell variant, columnar cell variant, solid variant, and hobnail variant. METHODS We have performed a review of the more aggressive variants of PTC with respect to main characteristics, histological and molecular features, and the consequences that the knowledge of these variants should have in the treatment of the patients. RESULTS At the present time, we do not know the prognostic value of these aggressive PTC variants. The extent of the surgical treatment and adjuvant therapy necessary should be decided on the basis of the extent of the tumor at presentation and the opinion of experienced clinicians. CONCLUSION These aggressive variants should be known by clinicians, to avoid underdiagnosis, and treated according to the latest recommendations in the literature.enAggressive variants papillary thyroid cancer Columnar cell variant Diffuse sclerosis variant Hobnail variant Solid variant Tall cell variant600 - Technology::610 - Medicine & healtharticle10.48350/1503473248865710.1007/s12325-020-01391-1